Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii

Špunarová,  Michaela; Pavlová,  Šárka; Tom,  Nikola; Borský,  Marek; Brychtová,  Yvona; Doubek,  Michael; Panovská,  Anna; Skuhrová Francová,  Hana; Brzobohatá,  Andrea; Freibergerová,  Anna; Mráz,  Marek; Pospíšilová,  Šárka; Mayer,  Jiří; Trbušek,  Martin

Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line
Authors	ŠPUNAROVÁ Michaela PAVLOVÁ Šárka TOM Nikola BORSKÝ Marek BRYCHTOVÁ Yvona DOUBEK Michael PANOVSKÁ Anna SKUHROVÁ FRANCOVÁ Hana BRZOBOHATÁ Andrea FREIBERGEROVÁ Anna MRÁZ Marek POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin
Year of publication	2018
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line, Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line.
Related projects:	Predictive stratification of CLL patients for therapy involving monoclonal antibodies targeting CD20 Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V